Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close
FR COVID-19 Contact us

Make a donation

Related Disorders

Amyloidosis

  • Amyloidosis is a collection of conditions occurring when an abnormal protein, known as amyloid, that is made by the plasma cells collects in body organs, such as the kidney, the gastrointestinal tract, the heart or the nervous system.
  • Although approximately 10% to 15% of people with myeloma will have or develop amyloidosis, it is rare for people with amyloidosis to develop myeloma.
  • Amyloidosis is usually treated with chemotherapy, using the same drugs that are used to treat myeloma.    

Waldenstrom's macroglobulinemia

  • Waldenstrom's macroglobulinemia is a rare form of plasma cell cancer characterized by an uncontrolled production of IgM, which causes the blood to thicken.
  • Symptoms can include: an enlargement of the nymph nodes, spleen or liver; fatigue caused by anemia; headaches; weight loss; a tendency to bleed easily; visual problems; confusion; and dizziness.
  • In extreme cases, the increased levels of IgM in the blood can lead to heart failure.

Light chain deposition disease (LCDD)

  • LCDD occurs in a very small percentage of myeloma patients, as a result of abnormal light chains collecting in organs, such as the kidneys.

POEMS syndrome

  • POEMS syndrome is a rare blood disorder associated with an uncommon type of myeloma called osteosclerotic myeloma and a condition known as Castleman's disease.
  • POEMS syndrome affects roughly twice as many men (who, on average are diagnosed at 50 years of age) as women (who are more likely to be diagnosed at around 60 years of age). 

 

Next

We’re here to help.

Join our community and sign up for our newsletter.

Sign up now